Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a)
Clinical trial NCT07496463 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07496463
- Sponsor
- Massachusetts General Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-21
- Primary completion
- 2027-04-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.